Xencor Inc
XNCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326732
No open-market purchases or sales by Xencor Inc insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Xencor Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 201
- +9 vs. Q4 2023
- Shares held
- 65.0M
- +1.70M (+2.7%) vs. Q4 2023
- Total value
- $1.44B
- +$94.7M (+7.0%) vs. Q4 2023
- New holders
- 32
- 71 more added
- Sold out
- 23
- 68 more reduced
3 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XNCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $1.36B |
| Q1 2026 | 203 | $1.02B |
| Q4 2025 | 208 | $1.25B |
| Q3 2025 | 206 | $960.2M |
| Q2 2025 | 194 | $646.9M |
| Q1 2025 | 202 | $837.9M |
| Q4 2024 | 192 | $1.72B |
| Q3 2024 | 210 | $1.45B |
| Q2 2024 | 198 | $1.20B |
| Q1 2024 | 201 | $1.44B |
| Q4 2023 | 195 | $1.35B |
| Q3 2023 | 178 | $1.27B |
| Q2 2023 | 182 | $1.57B |
| Q1 2023 | 188 | $1.77B |
| Q4 2022 | 197 | $1.60B |
| Q3 2022 | 186 | $1.58B |
| Q2 2022 | 176 | $1.64B |
| Q1 2022 | 181 | $1.58B |
| Q4 2021 | 178 | $2.37B |
| Q3 2021 | 170 | $1.90B |
| Q2 2021 | 178 | $2.00B |
| Q1 2021 | 170 | $2.52B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Xencor Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 11,054,641 | $244.6M | 0.01% | −268,669−2.4% | Reduced |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,351,367−100.0% | Sold out |
| Segall Bryant & Hamill, LLC | 0 | $0 | 0.00% | −154,824−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −47,666−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −45,849−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −36,249−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −27,167−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −23,601−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −21,421−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −17,549−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −17,546−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −10,594−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −8,300−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −6,967−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −5,418−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,436−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −435−100.0% | Sold out |
| SYSTM Wealth Solutions LLC | 0 | $0 | 0.00% | −258−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Cannell Peter B & Co Inc | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |